Related Experiment Videos
Brain abscess caused by Cladosporium trichoides
Archives of Internal Medicine
|April 1, 1976
Summary
Cladosporiosis treatment remains challenging, with limited success. While flucytosine showed some efficacy in eradicating the fungus in one patient, resistance developed in another, highlighting treatment complexities.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Cladosporiosis is a rare fungal infection with a historically poor prognosis.
- No consistently effective therapeutic strategies have been established for cladosporiosis.
- Previous reports indicate a high mortality rate, typically within one year of diagnosis.
Observation:
- Two patients with cladosporiosis were treated with flucytosine.
- Pre-treatment fungal isolates exhibited susceptibility to flucytosine at concentrations of 6.2 µg/ml and 3.1 µg/ml.
- Both patients ultimately succumbed to the infection.
Findings:
- Post-mortem examination revealed complete eradication of the fungus in one patient.
- In the second patient, the causative agent, Cladophialophora trichoides, demonstrated acquired resistance to flucytosine post-treatment.
- Flucytosine exhibited fungistatic or fungicidal activity in vitro, but clinical outcomes were poor.
Implications:
- Flucytosine may have a role in managing cladosporiosis, potentially leading to fungal clearance in some cases.
- The development of flucytosine resistance in Cladophialophora trichoides is a significant clinical concern.
- Further research is needed to develop more robust and reliable therapeutic regimens for cladosporiosis.